← Browse by Condition
Medical Condition

fgfr2 fusion

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06439485 Phase 1, Phase 2
Recruiting

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion

Enrollment
25 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →